Eye-Tracking Interaction System for Non-verbal ICU Patients
NCT ID: NCT07205419
Last Updated: 2025-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2026-04-01
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Researchers will compare the eye-tracking interactive system with traditional augmentative and alternative communication (AAC) technologies (such as body language, writing boards, etc.) to observe the feasibility and preliminary effectiveness of the eye-tracking interactive system in improving communication disorders.
Participants will:
* Use augmentative and alternative communication technologies daily
* Have detailed records of every communication interaction
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Eye Movement Tracking Systems for Visual Rehabilitation
NCT00013429
Eye-tracking Technology for Severe Communication Disability
NCT05808478
Non-Invasive Eye Tracking for the Diagnosis of Delirium on ICU
NCT04589169
Noninvasive Brain Stimulation in Adult Amblyopia
NCT06712849
Safety and Feasibility of the EyeControl Device
NCT02891629
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group:
Charge nurses will lead communication through body language (e.g., pointing, nodding, shaking the head) or by providing writing boards for patients to write. Patients unable to write will communicate solely through body language.
No interventions assigned to this group
Intervention Group
Charge nurses will lead communication using the eye-tracking interaction system. An eye-tracking interaction system refers to an eye-tracking interaction interface installed on any electronic device equipped with a camera that meets the configuration requirements.
Eye-Tracking Interaction System
The eye-tracking interactive interface designed based on evidence-based and co-design principles is installed on tablets or computers equipped with cameras, forming the eye-tracking interactive system.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eye-Tracking Interaction System
The eye-tracking interactive interface designed based on evidence-based and co-design principles is installed on tablets or computers equipped with cameras, forming the eye-tracking interactive system.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients in the ICU who are unable to communicate through normal verbal means due to endotracheal intubation/tracheotomy, muscle or nerve injury, acute/chronic spinal cord injury, etc.
* Richmond Agitation-Sedation Scale (RASS) score of -1 to 1;④Primary caregivers are adults
* Able to read Chinese characters and follow simple commands
* Willing to participate in this study
Exclusion Criteria
* A history of mental disorders, dementia or pre-dementia, or intellectual disability
* Conditions precluding cooperation with eye-tracking interaction, such as blindness or inability to elevate the eyelids
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Zhongshan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZS202500100
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.